based on configuration
The next step in the development of solid-phase techniques includes applications for peptides containing non-native amino acids, post-translationally modified amino acids, and pseudoamino acids, as well as for organic molecules in general. Several areas of solid-phase synthesis need to be refined to allow for the successful construction of this next generation of biomolecules. The solid support must be versatile so that a great variety of solvents can be used, particularly for organic-molecule applications. Coupling reagents must be sufficiently rapid so that sterically hindered amino acids can be incorporated. Construction of peptides that contain amino acids bearing post-translational modifications should take advantage of the solid-phase approach. Finally, appropriate analytical techniques are needed to assure the proper composition of products.
Successful SPPS depends upon the choice of the solid support, linker (between the solid support and the synthesized peptide), appropriately protected amino acids, coupling methodology, and protocol for cleaving the peptide from the solid support ( Fields, 1997 ). Choosing the right solid support is often paramount for successful, non-problematic synthesis of the desired peptide. Currently, there are a vast number of commercially available resins, suitable for complex peptide synthesis. It has to be noted that effective solvation of the peptide/resin is perhaps the most crucial condition for efficient chain assembly during solid-phase synthesis. Swollen resin beads may be reacted and washed batch-wise with agitation, then filtered either with suction or under positive nitrogen pressure. Alternatively, they may be packed in columns and utilized in a continuous-flow mode by pumping reagents and solvents through the resin ( Lukas et al., 1981 ). 1 H, 2 H, 13 C, and 19 F nuclear magnetic resonance (NMR) experiments have shown that, under proper solvation conditions, the linear polystyrene chains of copoly(styrene-1%-divinylbenzene) resin (PS) are nearly as accessible to reagents as if free in solution ( Albericio et al., 1989 ; Ford and Balakrishnan, 1981 ; Live and Kent, 1982 ; Ludwick et al., 1986 ; Manatt et al., 1980 ). 13 C and 19 F NMR studies of Pepsyn (copolymerized dimethylacrylamide, N,N '-bisacryloylethylenediamine, and acryloylsarcosine methyl ester) have shown similar mobilities at resin-reactive sites as PS. Additional supports created by grafting polyethylene glycol (polyoxyethylene) onto PS [either by controlled anionic polymerization of ethylene oxide on tetraethylene glycol–PS (POE-PS) or by coupling N ω -Boc– or Fmoc–polyethylene glycol acid or –polyethylene glycol diacid to amino-functionalized PS (PEG-PS)] combine the advantages of liquid-phase synthesis (i.e., a homogeneous reaction environment) and solid-phase synthesis (an insoluble support). 13 C NMR measurements of POE-PS showed the polyoxyethylene chains to be more mobile than the PS matrix, with the highest T 1 spin-lattice relaxation times observed with POE of molecular weight 2000 to 3000. Other supports that show improved solvation properties and/or are applicable to organic synthesis include polyethylene glycol polyacrylamide (PEGA), cross-linked acrylate ethoxylate resin (CLEAR), and augmented surface polyethylene prepared by chemical transformation (ASPECT). As the solid-phase method has expanded to include organic-molecule and library syntheses, the diversity of supports will enhance the efficiency of these new applications.
Successful syntheses of problematic sequences can be achieved by manipulation of the solid support. In general, the longer the synthesis, the more polar the peptide/resin will become ( Sarin et al., 1980 ). One can alter the solvent environment and enhance coupling efficiencies by adding polar solvents and/or chaotropic agents ( Fields and Fields, 1994 ). Also, using a lower substitution level of resin to avoid interchain crowding can improve the synthesis ( Tam and Lu, 1995 ). During difficult syntheses, deprotection of the Fmoc group can proceed slowly. By spectrophotometrically monitoring deprotection as the synthesis proceeds, one can detect problems and extend base-deprotection times and/or alter solvation conditions as necessary.
Solid phase peptide synthesis is traditionally carried out in the C → N direction. The majority of peptides are being synthesized as C-terminal acids or amides. For synthesis of C-terminal modified peptides one can take advantage of many linkers that are available ( Guillier et al., 2000 ). The use of linkers provides control and flexibility of the synthetic process, e.g., functionalization of the C-terminal amino acid, loading of the C-terminal amino acid, and/or cleavage conditions utilized for liberation of the peptide following synthesis.
The term coupling refers to formation of a peptide bond between two adjacent amino acids. Coupling involves attack of the amino group of one residue at the carbonyl group of the carboxy-containing component that has been activated by an electron withdrawing group. The activated form of the amino acid can be a shelf-stable reagent, compound of intermediate stability, or a transient intermediate which is neither isolable nor detectable ( El-Faham and Albericio, 2011 ).
The classical examples of in situ coupling reagents are N,N '-dicyclohexylcarbodiimide (DCC) and the related N,N '-diisopropylcarbodiimide ( Rich and Singh, 1979 ). The generality of carbodiimide-mediated couplings is extended significantly by the use of either 1-hydroxybenzotriazole (HOBt) or 1-hydroxy-7-azabenzotriazole (HOAt) as an additive, either of which accelerates carbodiimide-mediated couplings, suppresses racemization, and inhibits dehydration of the carboxamide side chains of Asn and Gln to the corresponding nitriles. Protocols involving benzotriazol-1-yl-oxy-tris(dimethylamino)phosphonium hexafluorophosphate (BOP), benzotriazol-1-yl-oxy-tris(pyrrolidino)phosphonium hexafluorophosphate (PyBOP), 7-azabenzotriazol-1-yl-oxytris(pyrrolidino)phosphonium hexafluorophosphate (PyAOP), O -benzotriazol-1-yl- N,N,N ', N '-tetramethyluronium hexafluorophosphate (HBTU), O -(7-azabenzotriazol-1-yl)- N,N,N ' N '-tetramethyluronium hexafluorophosphate (HATU), O-(6-Chlorobenzotriazol-1-yl)-N, N,N',N'-tetramethyluronium hexafluorophosphate (HCTU), and O -benzotriazol-1-yl- N,N,N',N '-tetramethyluronium tetrafluoroborate (TBTU) result in coupling kinetics even more rapid than that obtained with carbodiimides. Amino acid halides have also been applied to SPPS. N α -protected amino acid chlorides have a long history of use in solution synthesis. Fmoc–amino acid chlorides and fluorides react rapidly under SPPS conditions in the presence of HOBt/ N,N -diisopropylethylamine (DIEA) and DIEA, respectively, with very low levels of racemization. For convenience, tetramethylfluoroformamidinium hexafluorophosphate (TFFH) can be used for automated preparation of Fmoc–amino acid fluorides. Amino acid fluorides have been found to be especially useful for the preparation of peptides containing sterically hindered amino acids, such as peptaibols. Other coupling agents that result in low levels of epimerization, and thus are particularly useful for head-to-tail peptide cyclizations and fragment condensations, include O-(3,4-dihydro-4-oxo-1,2,3-benzotriazine-3-yl)-N,N, N',N'-tetramethyluronium tetrafluoroborate (TDBTU) and 3-(diethylphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one (DEPBT). All of the coupling reagents and additives discussed here are commercially available ( Table 18.1.2 ).
Peptide synthesis reagents suppliers list. [*Gwen: remove boxes so it's just a simple list.]
1 | AAPPTec |
2 | Acros Organics |
4 | Advanced ChemTech |
5 | AGTC Bioproducts |
6 | Anaspec |
7 | Applied Biosystems |
8 | Auspep |
9 | Bachem |
10 | Biopeptek |
12 | CBL Biopharma |
13 | Chem-Impex |
14 | ChemPep |
15 | CHI Scientific |
16 | CS Bio |
17 | CSPS Pharmaceuticals |
18 | EMD Chemicals |
19 | Fluka |
20 | GL Biochem |
21 | INBIOS S.r.l. |
24 | Luxembourg Bio Technologies |
25 | Midwest Bio-Tech |
26 | Mimotopes |
27 | Neuland Laboratories |
28 | New England Peptides |
29 | Omegachem |
30 | ORPEGEN |
31 | Pentabiotech |
33 | Peptides International |
34 | Polymer Laboratories |
35 | Polypeptide Laboratories |
36 | Rapp Polymere |
37 | Reanal Finechemical Private |
38 | RS Synthesis |
39 | Ryss Laboratory |
40 | Senn Chemicals |
41 | Sigma-Aldrich |
42 | Sussex Research |
43 | Syd Labs |
44 | Synthetech |
45 | TCI America |
46 | Toronto Research Chemicals |
Peptides of biological interest often include structural elements beyond the 20 genetically encoded amino acids. Particular emphasis has been placed on peptides containing phosphorylated or glycosylated residues or disulfide bridges. Incorporation of side-chain-phosphorylated Ser and Thr by SPPS is especially challenging, as the phosphate group is decomposed by strong acid and lost with base in a β-elimination process. Boc-Ser(PO 3 phenyl 2 ) and Boc-Thr(PO 3 phenyl 2 ) have been found to be useful derivatives, where hydrogen fluoride (HF) or hydrogenolysis cleaves the peptide/resin and hydrogenolysis removes the phenyl groups. Fmoc-Ser(PO 3 Bzl,H) and Fmoc-Thr(PO 3 Bzl,H) can be used in conjunction with Fmoc chemistry with some care ( Perich et al., 1999 ; Wakamiya et al., 1994 ). Alternatively, peptide/resins that were built up by Fmoc chemistry to include unprotected Ser or Thr side chains may be subject to “global” or post-assembly phosphorylation ( Otvös et al., 1989a ). Side-chain-phosphorylated Tyr is less susceptible to strong-acid decomposition and is not at all base-labile. Thus, SPPS has been used to incorporate directly Fmoc-Tyr(PO 3 methyl 2 ) ( Kitas et al., 1989 ), Fmoc-Tyr(PO 3 t Bu 2 ) ( Perich and Reynolds, 1991 ), Fmoc-Tyr(PO 3 H 2 ) ( Ottinger et al., 1993 ), and Boc-Tyr(PO 3 H 2 ) ( Zardeneta et al., 1990 ). Phosphorylation may also be accomplished on-line, directly after incorporation of the Tyr, Ser, or Thr residue but prior to assembly of the whole peptide ( Perich, 1997 ).
Methodology for site-specific incorporation of carbohydrates during chemical synthesis of peptides has developed rapidly. The mild conditions of Fmoc chemistry are more suited for glycopeptide syntheses than Boc chemistry, as repetitive acid treatments can be detrimental to sugar linkages. Fmoc-Ser, -Thr, -5-hydroxylysine (-Hyl), -4-hydroxyproline (-Hyp), and -Asn have all been incorporated successfully with glycosylated side chains ( Cudic and Burstein, 2008 ). The side-chain glycosyl is usually hydroxyl-protected by either benzoyl or acetyl groups, although some SPPSs have been successful with no protection of glycosyl hydroxyl groups ( Otvös et al., 1989b ). Deacetylation and debenzylation are performed with hydrazine/methanol prior to glycopeptide/resin cleavage or in solution with catalytic methoxide in methanol ( Sjölin et al., 1996 ).
Disulfide-bond formation has been achieved on the solid-phase by air, K 3 Fe(CN) 6 , dithiobis(2-nitrobenzoic acid), or diiodoethane oxidation of free sulfhydryls, by direct deprotection/oxidation of Cys(acetamidomethyl) residues using thallium trifluoroacetate or I 2 , by direct conversion of Cys(9-fluorenylmethyl) residues using piperidine, and by nucleophilic attack by a free sulfhydryl on either Cys(3-nitro-2-pyridinesulfenyl) or Cys( S -carboxymethylsulfenyl). The most generally applicable and efficient of these methods is direct conversion of Cys(acetamidomethyl) residues by thallium trifluoroacetate. In solution, disulfide formation may be mediated by a lengthy catalogue of reagents, the most straightforward of which are molecular O 2 (from air) and DMSO ( Tam et al., 1991 ).
Intra-chain lactams are formed between the side-chains of Lys or Orn and Asp or Glu to conformationally restrain synthetic peptides, with the goal of increasing biological potency and/or specificity. Lactams can also be formed via side-chain-to-head, side-chain-to-tail, or head-to-tail cyclization ( Kates et al., 1994 ). The residues used to form intra-chain lactams must be selectively side-chain deprotected, while all side-chain protecting groups of other residues remain intact. Selective deprotection is best achieved by using orthogonal side-chain protection, such as allyloxycarbonyl or 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl protection for Lys and allyl or N -[1-(4,4,-dimethyl-2,6-dioxocyclohexylidene)-3-methyl butyl]aminobenzyl protection for Asp/Glu in combination with an Fmoc/ t Bu strategy. Cyclization is carried out most efficiently with BOP in the presence of DIEA while the peptide is still attached to the resin ( Felix et al., 1988 ; Plaue, 1990 ).
The three-dimensional orthogonal protection scheme of Fmoc/ t Bu/allyl protecting groups is the strategy of choice for head-to-tail cyclizations. An amide linker is used for side-chain attachment of a C-terminal Asp/Glu (which are converted to Asn/Gln) and the α-carboxyl group is protected as an allyl ester ( Stawikowski and Cudic, 2006 ). For side-chain-to-head cyclizations, the N-terminal amino acid (head) can simply be introduced as an N α -Fmoc derivative while the peptide-resin linkage and the other side-chain protecting groups are stable to dilute acid or carry a third dimension of orthogonality.
There are three general chemical approaches for constructing proteins. First is stepwise synthesis, in which the entire protein is synthesized one amino acid at a time. Second is “fragment assembly,” in which individual peptide strands are initially constructed stepwise, purified, and finally covalently linked to create the desired protein. Fragment assembly can be divided into two distinct approaches: (1) convergent synthesis of fully protected fragments, and (2) chemoselective ligation of unprotected fragments. Third is “directed assembly,” in which individual peptide strands are constructed stepwise, purified, and then noncovalently driven to associate into protein-like structures. Combinations of the three general chemical approaches may also be employed for protein construction.
Convergent synthesis utilizes protected peptide fragments for protein construction ( Albericio et al., 1997 ). The advantage of convergent protein synthesis is that fragments of the desired protein are first synthesized, purified, and characterized, ensuring that each fragment is of high integrity; these fragments are then assembled into the complete protein. Thus, cumulative effects of stepwise synthetic errors are minimized. Convergent synthesis requires ready access to pure, partially protected peptide segments, which are needed as building blocks. The application of solid-phase synthesis to prepare the requisite intermediates depends on several levels of selectively cleavable protecting groups and linkers. Methods for subsequent solubilization and purification of the protected segments are nontrivial. Individual rates for coupling segments are substantially lower than for activated amino acid species by stepwise synthesis, and there is always a risk of racemization at the C-terminus of each segment. Careful attention to synthetic design and execution may minimize these problems.
As an alternative to the segment condensation approach, methods have been developed by which unprotected peptide fragments may be linked. “Native chemical ligation” results in an amide bond being generated between peptide fragments (see UNIT 18.4 ) ( Muir et al., 1997 ). A peptide bearing a C-terminal thioacid is converted to a 5-thio-2-nitrobenzoic acid ester and then reacted with a peptide bearing an N-terminal Cys residue ( Dawson et al., 1994 ). The initial thioester ligation product undergoes spontaneous rearrangement, leading to an amide bond and regeneration of the free sulfhydryl on Cys. The method was later refined so that a relatively unreactive thioester can be used in the ligation reaction ( Ayers et al., 1999 ; Dawson et al., 1997 ). “Safety-catch” linkers are used in conjunction with Fmoc chemistry to produce the necessary peptide thioester ( Shin et al., 1999 ). Safety-catch linkers anchor the nascent peptide to the resin and are stable throughout the synthesis. These linkers then allow the release of a C -terminally modified peptide from the solid support under mild conditions following an additional activation step.
The free N α -amino group of an anchored dipeptide is poised for a base-catalyzed intramolecular attack of the C-terminal carbonyl. Base deprotection of the Fmoc group can thus release a cyclic diketopiperazine while a hydroxymethyl-handle leaving group remains on the resin. With residues that can form cis peptide bonds, e.g., Gly, Pro, N -methylamino acids, or d -amino acids, in either the first or second position of the ( C → N ) synthesis, diketopiperazine formation can be substantial. The steric hindrance of the 2-chlorotrityl linker may minimize diketopiperazine formation of susceptible sequences during Fmoc chemistry.
The conversion of side-chain protected Asp residues to aspartimide residues can occur by repetitive base treatments. The cyclic aspartimide can then react with piperidine to form the α- or β-piperidide or α- or β-peptide. Aspartimide formation can be rapid, and is dependent upon the Asp side-chain protecting group. Sequence dependence studies of Asp(O t Bu)-X peptides revealed that piperidine could induce aspartimide formation when X = Arg(2,2,5,7,8-pentamethylchroman-6-sulfonyl; Pmc), Asn(triphenylmethyl; Trt), Asp(O t Bu), Cys(Acm), Gly, Ser, Thr, and Thr( t Bu) ( Lauer et al., 1995 ). Aspartimide formation can also be conformation-dependent. This side-reaction can be minimized by including 0.1 M HOBt in the piperidine solution ( Lauer et al., 1995 ), or by using an amide backbone protecting group (i.e., 2-hydroxy-4-methoxybenzyl) for the residue in the X position of an Asp-X sequence ( Quibell et al., 1994 ).
Cys residues are racemized by repeated piperidine deprotection treatments during Fmoc SPPS. Racemization of esterified (C-terminal) Cys can be reduced by using 1% 1,8-diazabicyclo[5.4.0]undec-7-ene in N,N -dimethylformamide (DMF). Additionally, the steric hindrance of the 2-chlorotrityl linker minimizes racemization of C-terminal Cys residues. When applying protocols for Cys internal (not C-terminal) incorporation which include phosphonium and aminium salts as coupling agents, as well as preactivation in the presence of suitable additives and tertiary amine bases, significant racemization is observed. Racemization is generally reduced by avoiding preactivation, using a weaker base (such as collidine), and switching to the solvent mixture DMF-dichloromethane (DCM) (1:1). Alternatively, the pentafluorophenyl ester of a suitable Fmoc-Cys derivative can be used.
The combination of side-chain protecting groups and anchoring linkages commonly used in Fmoc chemistry are simultaneously deprotected and cleaved by TFA. Cleavage of these groups and linkers results in liberation of reactive species that can modify susceptible residues, such as Trp, Tyr, and Met. Modifications can be minimized during TFA cleavage by utilizing effective scavengers. Three efficient cleavage “cocktails” quenching reactive species and preserving amino acid integrity, are (1) TFA-phenolthioanisole-1,2-ethanedithiol-H 2 O (82.5:5:5:2.5:5) (reagent K) ( King et al., 1990 ), (2) TFA-thioanisole-1,2-ethanedithiol-anisole (90:5:3:2) (reagent R) ( Albericio et al., 1990 ), and (3) TFA-phenol-H 2 O-triisopropylsilane (88:5:5:2) (reagent B) ( Solé and Barany, 1992 ). The use of Boc side-chain protection of Trp also significantly reduces alkylation by Pmc or 2,2,4,6,7-pentamethyldihydro-benzofuran-5-sulfonyl (Pbf) groups. For a list of common problems encountered during peptide synthesis refer to Table 18.1.3 .
Common problems encountered during peptide synthesis.
Problem | Solutions | Reference |
---|---|---|
Diketopiperazine formation | • Use of 2-chlorotrityl linker | ( ; ) |
Aspartamide formation | • May be minimized by addition of 0.1 M HOBt in the piperidine solution | ( ) |
• Use of amide backbone protecting group | ( ) | |
Racemization of C-terminal Cys | • Use of 2-chlorotrityl linker | ( ) |
• Use 1% DBU in DMF | ||
Modification of amino acids during cleavage | ||
If present: Cys(Trt), Met, Trp(Boc) | • Use Reagent K: TFA/phenol/water/thioanisole/EDT (82.5/5/5/5/2.5) | ( ) |
• Do not use when Cys(Acm) is present | ||
If present: Arg(Mtr/Pmc), Arg(Pbf), Asn(Mbh/Tmob), Gln(Mbh/Tmob), Trp(any), Met, Cys(any), His(any) | • Use Reagent R: TFA/thioanisole/EDT/anisole (90/5/3/2) or | ( ) |
• Use Reagent B: TFA/phenol/water/triisopropylsilane (88/5/5/2) | ( ) |
Each synthetic procedure has limitations, and even in the hands of highly experienced workers, certain sequences defy facile preparation. The maturation of high-performance liquid chromatography (HPLC) has been a major boon to modern peptide synthesis, because the resolving power of this technique facilitates removal of many of the systematic low-level by-products that accrue during chain assembly and upon cleavage. Peptide purification is most commonly achieved by reversed-phase HPLC (RP-HPLC; UNIT 11.6 ). Either alternatively to or in tandem with RP-HPLC, ion-exchange HPLC ( UNIT 8.2 ) and gel-filtration HPLC ( UNIT 8.3 ) can be used for isolation of desired peptide products. The progress of peptide purification can be monitored rapidly by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS; UNIT 16.2 & 16.3 ) or ion-trap electrospray MS ( UNIT 16.8 ).
The homogeneity of synthetic materials should be checked by at least two chromatographic or electrophoretic techniques, e.g., RP-HPLC ( UNIT 11.6 ), ion-exchange HPLC ( UNIT 8.2 ), and capillary zone electrophoresis ( UNIT 10.9 ). Also, determination of a molecular ion by MS (see Chapter 16) using a mild ionization method is important for proof of structure. Synthetic peptides must be checked routinely for the proper amino acid composition, and in some cases sequencing data are helpful. The PSRC studies (see discussion of Development of Solid-Phase Peptide Synthesis Methodology) have allowed for a side-by-side comparison of a variety of analytical techniques. Efficient characterization of synthetic peptides best been obtained by a combination of RP-HPLC and MS, with sequencing by either Edman degradation sequence analysis or tandem MS ( UNIT 16.1 ) being used to identify the positions of modifications and deletions. Proper peptide characterization by multiple techniques is essential.
Home / Introduction to Peptide Synthesis
By James Ashenhurst
Last updated: February 9th, 2023 |
Peptide bonds: Forming peptides from amino acids with the use of protecting groups
Today we’ll go deeper on how to synthesize the most important amides of all – peptides – with an important contribution from protecting group chemistry.
Table of Contents
1. what are peptide bonds.
A “peptide bond” is an amide linkage (see Amides: Properties. Synthesis, and Nomenclature ) that connects two amino acids, as in the “dipeptides” L-phenylalanyl-L-valine (below left) and L-leucyl-L-alanine (below right):
Proteinogenic amino acids are the building blocks of proteins. In addition to the 20 amino acids directly encoded by the genome, two other amino acids are coded into proteins under special circumstances: selenocysteine (present in eukaryotes, including humans) and pyrrolysine (found only in methane-producing bacteria).
With the exception of (achiral) glycine, all proteinogenic amino acids are L-amino acids, where the “L-” prefix relates the stereochemistry of the amino acid relative to that of L-glyceraldehyde [See post: D and L Sugars ] .
Of the chiral amino acids, all are S , with the exception of cysteine and selenocysteine [ Note 1 ] (because sulfur and selenium have a higher priority under the CIP system. )
Let’s build a simple dipeptide between two of these amino acids. For simplicity’s sake, we’ll pick two from the “hydrophobic sidechain” group, alanine (Ala) and leucine (Leu), since their sidechains don’t need additional protecting groups.
What do we need to do to make L-Ala-L-Leu ?
Surveying the methods previously covered to make amides, it might seem simple.
Why not take 1 equivalent each of L-alanine and L-phenylalanine, add a coupling agent like N,N -dicyclohexylcarbodiimide (DCC) and patiently wait for our product to appear?
What could possibly go wrong?
Well, this will give us some of our desired product. But it won’t do so efficiently!
That’s because each amino acid has two reactive termini – an amine and a carboxylic acid – and they can bond together in multiple ways.
Just like the letters A and L can combine to make the words AL and LA, in addition to Ala-Leu (our desired product) we will also get Leu-Ala.
Furthermore, since we’re not adding single molecules together but molar quantities (even a millionth of a mole (a “micromole”) has 10 17 molecules in it) we also have the possibility of forming the “homo-dipeptides” AA (Ala-Ala) and LL (Leu-Leu).
And that’s just a start. No matter how you slice it you’re looking at a low yield (<25%) of the desired material.
That’s inefficient, wasteful, and expensive! Isn’t there a better way?
Yes. Rather than using the native amino acids and just praying for a good yield, we can use protected versions of L-Alanine and L-Leucine.
If we protect the carboxylic acid of Leucine as an ester (e.g. a methyl ester) and protect the amine of L-Alanine as a carbamate (See: Carbamates as protecting groups ) then we set up a situation where we have a single nucleophile and a single electrophile.
This results in a high yield (>95%) of a single product!
[Note: the Boc group is a popular carbamate protecting group for amines; “Boc” stands for t-butyloxycarbonyl]
The good news is that we don’t have to stop at the dipeptide. If we choose protecting groups that can be removed selectively (and the carbamate / ester pair qualifies) then we can then deprotect the carbamate, and add a third amino acid.
The choice of carbamate protecting group here was t -butoxycarbonyl (Boc) which is removed with strong acid (trifluoroacetic acid, abbreviated as TFA).
Treatment with TFA removes the Boc group but leaves the methyl ester alone.
So if we treat the dipeptide with TFA, we liberate the amine nitrogen, and can react with another Boc-protected amino acid in the presence of DCC to get a tripeptide.
If we’re keen, we can even extend the same method to build a tetrapeptide, a pentapeptide… or beyond!
It’s not unreasonable to consider this method for longer peptides.
For instance, take something like bradykinin , a 9-peptide chain that causes dilation of blood vessels leading to a rapid drop in blood pressure. (Your body releases bradykinin in response to snake bites, which is how it was originally discovered.)
It might be interesting to synthesize variants of bradykinin where some of the amino acids are swapped out for other ones. In order to do that, we’d need to be able to synthesize it.
So how effective could it be?
If each peptide coupling step has a yield of about 95%, then our overall yield for making bradykinin would be (0.95) 9 , or 63%. That’s actually pretty good! A lot of chemists would be happy to get a yield of 63% for a single reaction, let me tell you.
If the yields are high enough, one can even imagine building something crazy like insulin (51 peptide residues). That’s 7% yield for 51 steps.
Is this possible?
Yes… but it requires a clever modification that won its inventor, Bruce Merrifield, the 1984 Nobel Prize in Chemistry.
What follows below is more supplemental than anything else, but given the importance of the topic, both interesting and useful.
In 1963 a chemist at Rockefeller University named Bruce Merrifield published a paper that would revolutionize how peptides were synthesized, and eventually make the synthesis of long peptides routine.
It was entitled: “ Solid-Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide “.
Here’s the key idea.
Recall that in our original scheme (above) we protected the carboxylic acid as a methyl ester, which stays the same throughout the whole peptide synthesis.
Merrifield’s idea was: what if we find a way to attach the carboxylic acid to a functional group that is itself linked to a polymer bead ? Not only would this also protect the carboxylic acid, it would drastically improve the ease of separations.
Why? Because instead of having to purify the final product by crystallization or column chromatography, you purify by filtering off the polymer beads (each 200-500 μm) and washing them to remove excess reagents.
The polymer beads themselves are pretty small. A typical size is 200 micrometers. Each bead can load about 4 nanomoles of amino acid.
[ Brandon Finlay from ChemTips shows a picture here ]
The video posted below is not mine, but it gives you an idea of the process.
At about 0:34 you can see how small the beads are.
The starting point for the Merrifield process is crosslinked polystyrene. which behaves like one big interlinked molecule. Polystyrene is then attached to a linker, which usually terminates with an NH 2 group. This itself is usually protected; in order to activate the linker, you need to remove the protecting group cap.
The polymer bead needs to swell in a solvent in order for functional groups on the solid support to undergo reactions efficiently.
The essential procedure is: swell –> add reagents –> wait –> filter –> wash, and repeat. Beads stay in the reaction vessel the whole time. There’s also usually some kind of capping step to make sure any unreacted amines don’t participate in the next reaction.
It’s possible to make peptides up to about 50 units this way. In highly automated systems one can be even more ambitious.
Merrifield started knocking off peptides in the 1960s. Bradykinin was made in 8 days and 68% overall yield. one example. Insulin was made two years later. The crowning achievement of this initial period was probably ribonuclease A , which has 150 amino acid residues.
The original Merrifield process has been significantly modified and improved. Originally, removal of the linker required harsh conditions (strong acid). Today, procedures usually employ FMOC protecting groups instead of BOC, which allow for deprotection with mild amine base (piperidine). A galaxy of new resins, linkers, and coupling procedures have been subsequently developed. The Wikipedia article on solid-phase peptide synthesis is an OK place to start.
Related Articles
Note 1 . Cysteine (and selenocysteine) are L, but their stereocenters are (R) , because sulfur and selenium have higher priority within the Cahn-Ingold-Prelog system.
This is a major topic, as the synthesis of peptides is a global billion-dollar industry.
6 thoughts on “ introduction to peptide synthesis ”.
Thanks for very good explanation and excellent step-by-step video!!
These tips are awesome, I was looking for something like that. Thanks!
OK. Do you guys actually do peptide synthesis or do you just drop ship?
We, or least, in my school do cover this topic extensively. We need to learn fischer esterfication of them, acylation, protecting group although it was different than the protecting group you used It had two benzene rings and a five member ring in the middle.
Good to know! Sounds like you’re talking about FMOC. https://en.wikipedia.org/wiki/Fluorenylmethyloxycarbonyl_protecting_group
I should update to include that.
Thank you very much!
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me via e-mail if anyone answers my comment.
This site uses Akismet to reduce spam. Learn how your comment data is processed .
Search Thermo Fisher Scientific
Peptide synthesis is characterized as the formation of a peptide bond between two amino acids. While there is no definitive definition of a peptide, it usually refers to flexible (little secondary structure) chains of up to 30-50 amino acids.
The ability to form peptide bonds to link amino acids together is over 100 years old, although the first peptides to be synthesized, including oxytocin and insulin, did not occur for another 50-60 years, demonstrating the difficult task of chemically synthesizing chains of amino acids (1). In the last 50 years, advances in protein synthesis chemistry and methods have developed to the point where peptide synthesis today is a common approach in even high-throughput biological research and product and drug development (2).
The benefit of peptide synthesis strategies today is that besides having the ability to make peptides that are found in biological specimens, creativity and imagination can be tapped to generate unique peptides to optimize a desired biological response or other result. This page highlights the important aspects of peptide synthesis, the most common methods of synthesis and purification and the strengths and limitations of the respective strategies.
Applications of synthetic peptides.
The invention of peptide synthesis in the fifties and sixties spurred the development of different application areas in which synthetic peptides are now used, including the development of epitope-specific antibodies against pathogenic proteins, the study of protein functions and the identification and characterization of proteins. Furthermore, synthetic peptides are used to study enzyme-substrate interactions within important enzyme classes such as kinases and proteases, which play a crucial role in cell signaling.
In cell biology, receptor binding or the substrate recognition specificity of newly discovered enzymes can often be studied using sets of homologous synthetic peptides. Synthetic peptides can resemble naturally occurring peptides and act as drugs against cancer and other major diseases. Finally, synthetic peptides are used as standards and reagents in mass spectrometry (MS)-based applications. Synthetic peptides play a central role in MS-based discovery, characterization and quantitation of proteins, especially those that serve as early biomarkers for diseases.
Peptide synthesis most often occurs by coupling the carboxyl group of the incoming amino acid to the N-terminus of the growing peptide chain. This C-to-N synthesis is opposite from protein biosynthesis, during which the N-terminus of the incoming amino acid is linked to the C-terminus of the protein chain (N-to-C). Due to the complex nature of in vitro protein synthesis, the addition of amino acids to the growing peptide chain occurs in a precise, step-wise and cyclic manner. And while the common methods of peptide synthesis have some critical differences, they all follow the same step-wise method to add amino acids one-at-a-time to the growing peptide chain.
Because amino acids have multiple reactive groups, peptide synthesis must be carefully performed to avoid side reactions that can reduce the length and cause branching of the peptide chain. To facilitate peptide formation with minimal side reactions, chemical groups have been developed that bind to the amino acid reactive groups and block, or protect, the functional group from nonspecific reaction.
Purified, individual amino acids used to synthesize peptides are reacted with these protecting groups prior to synthesis, and then specific protecting groups are removed from the newly added amino acid (a step called deprotection) just after coupling to allow the next incoming amino acid to bind to the growing peptide chain in the proper orientation. Once peptide synthesis is completed, all remaining protecting groups are removed from the nascent peptides. Three types of protecting groups are generally used, depending on the method of peptide synthesis, and are described below.
The amino acid N-termini are protected by groups that are termed "temporary" protecting groups, because they are relatively easily removed to allow peptide bond formation. Two common N-terminal protecting groups are tert-butoxycarbonyl ( Boc ) and 9-fluorenylmethoxycarbonyl ( Fmoc ), and each group has distinct characteristics that determine their use. Boc requires a moderately strong acid such as trifluoracetic acid (TFA) to be removed from the newly added amino acid, while Fmoc is a base-labile protecting group that is removed with a mild base such as piperidine.
Boc chemistry was first described in the 1950s and requires acidic conditions for deprotection, while Fmoc, which was not reported for another twenty years, is cleaved under mild, basic conditions (3,4,5,6). Because of the mild deprotection conditions, Fmoc chemistry is more commonly used in commercial settings because of the higher quality and greater yield, while Boc is preferred for complex peptide synthesis or when non-natural peptides or analogs that are base-sensitive are required.
The use of a C-terminal protecting group depends on the type of peptide synthesis used; while liquid-phase peptide synthesis requires protection of the C-terminus of the first amino acid (C-terminal amino acid), solid-phase peptide synthesis does not, because a solid support (resin) acts as the protecting group for the only C-terminal amino acid that requires protection (see Protein Synthesis Strategies).
Amino acid side chains represent a broad range of functional groups and are therefore a site of considerable side chain reactivity during peptide synthesis. Because of this, many different protecting groups are required, although they are usually based on the benzyl (Bzl) or tert-butyl (tBu) group. The specific protecting groups used during the synthesis of a given peptide vary depending on the peptide sequence and the type of N-terminal protection used (see next paragraph). Side chain protecting groups are known as permanent protecting groups, because they can withstand the multiple cycles of chemical treatment during the synthesis phase and are only removed during treatment with strong acids after synthesis is complete.
Because multiple protecting groups are normally used in peptide synthesis, it is evident that these groups must be compatible to allow deprotection of distinct protecting groups while not affecting other protecting groups. Protecting schemes are therefore established to match protecting groups so that deprotection of one protecting group does not affect the binding of the other groups. Because N-terminal deprotection occurs continuously during peptide synthesis, protecting schemes have been established in which the different types of side chain protecting groups (Bzl or tBu) are matched to either Boc or Fmoc, respectively, for optimized deprotection. These protecting schemes also incorporate each of the steps of synthesis and cleavage, as described in the table and in later sections of this page.
Protecting Scheme | Deprotection | Coupling | Cleavage | Wash |
---|---|---|---|---|
Boc/Bzl | TFA | Coupling agent in DMF | HF, HBr, TFMSA | DMF |
Fmoc/tBut | Piperidine | TFA |
Common protecting scheme-specific solvents .
The act of removing protecting groups, especially under acidic conditions, results in the production of cationic species that can alkylate the functional groups on the peptide chain. Therefore, scavengers such as water, anisol or thiol derivatives can be added in excess during the deprotection step to react with any of these free reactive species.
Synthetic peptide coupling requires the activation of the C-terminal carboxylic acid on the incoming amino acid using carbodiimides such as dicyclohexylcarbodiimide (DCC) or diisopropylcarbodiimide (DIC). These coupling reagents react with the carboxyl group to form a highly reactive O-acylisourea intermediate that is quickly displaced by nucleophilic attack from the deprotected primary amino group on the N-terminus of the growing peptide chain to form the nascent peptide bond.
Carbodiimides form such a reactive intermediate that racemization of the amino acid can occur. Therefore, reagents that react with the O-acylisourea intermediate are often added, including 1-hydroxybenzotriazole (HOBt), which forms a less-reactive intermediate that reduces the risk of racemization. Additionally, side reactions caused by carbodiimides have led to the examination of other coupling agents, including benzotriazol-1-yl-oxy-tris(dimethylamino)phosphonium hexafluorophosphate (BOP) and 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU), which both require activating bases to mediate amino acid coupling.
After successive cycles of amino acid deprotection and coupling, all remaining protecting groups must be removed from the nascent peptide. These groups are cleaved by acidolysis, and the chemical used for cleavage depends on the protection scheme used; strong acids such as hydrogen fluoride (HF), hydrogen bromide (HBr) or trifluoromethane sulfonic acid (TFMSA) are used to cleave Boc and Bzl groups, while a relatively milder acid such as TFA is used to cleave Fmoc and tBut groups. When properly executed, cleavage results in the removal of the N-terminal protecting group of the last amino acid added, the C-terminal protecting group (either chemical or resin) from the first amino acid and any side-chain protecting groups. As with deprotection, scavengers are also included during this step to react with free protecting groups. Because of the importance of cleavage in proper peptide synthesis, this step should be optimized to avoid acid-catalyzed side reactions.
Diagram of peptide cleavage after synthesis. The remaining N-terminal protecting groups, all side-chain protecting groups and the C-terminal protecting group or solid support are removed by strong acid treatment after peptide synthesis is completed.
Liquid-phase peptide synthesis is the classical method that scientists used when first discovering how to generate peptides in vitro and it is still commonly used for large-scale synthesis. This method is slow and labor-intensive, though, because the product has to be manually removed from the reaction solution after each step. Additionally, this approach requires another chemical group to protect the C-terminus of the first amino acid. A benefit of liquid-phase synthesis, though, is that because the product is purified after each step, side reactions are easily detected. Additionally, convergent synthesis can be performed, in which separate peptides are synthesized and then coupled together to create larger peptides.
By far, though, solid-phase peptide synthesis is the most common method of peptide synthesis today. Instead of C-terminal protection with a chemical group, the C-terminus of the first amino acid is coupled to an activated solid support, such as polystyrene or polyacrylamide. This type of approach has a two-fold function: the resin acts as the C-terminal protecting group and provides a rapid method to separate the growing peptide product from the different reaction mixtures during synthesis. As with many different biological manufacturing processes, peptide synthesizers have been developed for automation and high-throughput peptide production.
Although peptide synthesis strategies have been optimized and can be mass-produced, the process to generate peptides is by no means perfect. Events such as incomplete deprotection or reaction with free protecting groups can cause truncated or deletion sequences, isomers or other side products. These events can occur at any step during peptide synthesis, and therefore the longer the peptide sequence, the greater probability that something will negatively affect the synthesis of the target peptide. Thus, peptide yield is inversely correlated with peptide length.
Purification strategies are usually based on a combination of separation methods that exploit the physiochemical characteristics of peptides, including size, charge and hydrophobicity. Purification techniques include:
Reverse-phase chromatography (RPC) is the most versatile and most widely used method of peptide purification. With traditional methods of HPLC, the stationary phase captures polar, hydrophilic molecules that are then differentially eluted by increasing the concentration of polar solvents in the mobile phase. In RPC, as the name implies, hydrophobic molecules from aqueous solutions are instead captured by the stationary phase using hydrophobic C4, C8 or C18 n-alkyl hydrocarbon ligands, and their retention time is a function of the hydrophobicity of the molecule and that of the mobile phase.
For peptide purification, RPC separates the target peptides from impurities from the synthesis steps, such as isomers, deletion sequences, peptide products from side reactions with free coupling and protecting groups or peptides that have undergone side-chain reactions.
Peptide purity is measured as a percentage of the target peptide to impurities that absorb at the peptide bond absorption wavelength (210-220nm), and varying levels of purity are commercially available based on the application in which the peptides will be used:
For Research Use Only. Not for use in diagnostic procedures.
26.7 • Peptide Synthesis
Once the structure of a peptide is known, its synthesis can be undertaken—perhaps to obtain a larger amount for biological evaluation. A simple amide might be formed by treating an amine and a carboxylic acid with a carbodiimide (either DCC or EDC; Section 21.3 ), but peptide synthesis is a more difficult problem because many different amide bonds must be formed in a specific order, rather than at random.
The solution to the specificity problem is protection ( Section 17.8 ). If we want to couple alanine with leucine to synthesize Ala-Leu, for instance, we could protect the –NH 2 group of alanine and the –CO 2 H group of leucine to shield them from reacting, then form the desired Ala-Leu amide bond by reaction with EDC or DCC, and then remove the protecting groups.
A number of different amino- and carboxyl-protecting groups have been devised, but only a few are used in peptide synthesis. Carboxyl groups are often protected simply by converting them into methyl or benzyl esters. Both groups are easily introduced by standard methods of ester formation ( Section 21.6 ) and are easily removed by mild hydrolysis with aqueous NaOH. Benzyl esters can also be cleaved by catalytic hydrogenolysis of the weak benzylic C–O bond ( RCO 2 –CH 2 Ph + H 2 → RCO 2 H + PhCH 3 RCO 2 –CH 2 Ph + H 2 → RCO 2 H + PhCH 3 ).
Amino groups are sometimes protected as their tert -butyloxycarbonyl amide (Boc) or, more commonly, as their fluorenylmethyloxycarbonyl amide (Fmoc). The Boc protecting group is introduced by reaction of the amino acid with di- tert -butyl dicarbonate in a nucleophilic acyl substitution reaction and is removed by brief treatment with a strong acid such as trifluoroacetic acid, CF 3 CO 2 H. The Fmoc protecting group is introduced by reaction with fluorenylmethyloxycarbonyl chloride and is removed by treatment with a 20% solution of the amine piperidine in dimethylformamide as solvent.
Thus, five steps are needed to synthesize a dipeptide such as Ala-Leu:
These steps can be repeated to add one amino acid at a time to the growing chain or to link two peptide chains together. Many remarkable achievements in peptide synthesis have been reported, including a complete synthesis of human insulin. Insulin is composed of two chains totaling 51 amino acids linked by two disulfide bridges. The three-dimensional structure of insulin, shown previously, was determined by Dorothy Crowfoot Hodgkin, a British chemist who received the 1964 Nobel Prize in Chemistry for her work on this and other complex biological molecules.
This book may not be used in the training of large language models or otherwise be ingested into large language models or generative AI offerings without OpenStax's permission.
Want to cite, share, or modify this book? This book uses the Creative Commons Attribution-NonCommercial-ShareAlike License and you must attribute OpenStax.
Access for free at https://openstax.org/books/organic-chemistry/pages/1-why-this-chapter
© Aug 5, 2024 OpenStax. Textbook content produced by OpenStax is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License . The OpenStax name, OpenStax logo, OpenStax book covers, OpenStax CNX name, and OpenStax CNX logo are not subject to the Creative Commons license and may not be reproduced without the prior and express written consent of Rice University.
IMAGES
VIDEO
COMMENTS
Learn about the history and principles of peptide chemistry, from the first peptide synthesis by Fischer and Fourneau to the modern methods of solid phase peptide synthesis. Find out how to use Fmoc and Boc protecting groups, coupling reagents and co-reagents for peptide synthesis.
Learn about the chemical production of peptide molecules by condensation of amino acids, using classical or solid phase techniques. Find out how to choose the best coupling reagents, protecting groups and purification methods for your peptide synthesis.
Abstract. A number of synthetic peptides are significant commercial or pharmaceutical products, ranging from the dipeptide sugar-substitute aspartame to clinically used hormones, such as oxytocin, adrenocorticotropic hormone, and calcitonin. This unit provides an overview of the field of synthetic peptides and proteins.
Last updated: February 9th, 2023 |. Peptide bonds: Forming peptides from amino acids with the use of protecting groups. Today we’ll go deeper on how to synthesize the most important amides of all – peptides – with an important contribution from protecting group chemistry. Table of Contents.
Learn about peptide synthesis methods, applications, strategies and products from Thermo Fisher Scientific. Find out how to design, synthesize and purify peptides for protein biology research and drug development.
Learn how peptides are synthesized by coupling amino acids with protecting groups and removing them step by step. See examples of peptide synthesis and the structure of insulin.